Pharmacy

PhRMA CEO hopeful Trump administration will reconsider drug-pricing proposals

Steve Ubl, CEO of the Pharmaceutical Research and Manufacturers of America, said he remains "hopeful" the Trump administration will reconsider its proposal to lower drug prices, according to The Hill. By Alia Paavola - 1/17/19

Key thoughts on controlling pharmacy spend for hospitals

Sponsored

Hear from Geisinger Health System, Novant Health, UC San Diego Health and Seton Medical Center Hays on how they are controlling pharmacy spend.

Allergan, Mohawk tribe take patent case appeal to Supreme Court

Allergan and the St. Regis Mohawk Tribe will continue their legal battle in defense of a patent agreement struck in 2017, appealing a lower court decision to the U.S. Supreme Court, according to STAT. By Alia Paavola - 1/17/19
Purdue Pharma's opioid ties to Massachusetts General, Tufts: 10 things to know

Purdue Pharma formed relationships with two Boston-based organizations — Massachusetts General Hospital and Tufts University School of Medicine — to boost prescription rates and generate goodwill toward opioids as painkillers, according to a court filing released Jan. 15. By Alia Paavola - 1/17/19

AmerisourceBergen cuts half its workforce at Tennessee compounding plant

Pharmedium, AmerisourceBergen's troubled compounding unit, will lay off 225 workers at its Memphis, Tenn., facility by March 12, according to the Commercial Appeal. By Alia Paavola - 1/16/19
Pfizer closes 5 biosimilar R&D programs, sheds 150 jobs

Pfizer is ending five preclinical programs in its biosimilar research and development unit, which will result in 150 employees losing their jobs, according to a BioSpace news report. By Alia Paavola - 1/16/19
Unfazed by Amazon competition: 'They won't offer anything new,' CVS chief says

CVS has already sent shockwaves through the healthcare industry with its first-of-a-kind merger with health insurer Aetna — but its path to transforming healthcare won't stop there, CVS CEO Larry Merlo said at a National Press Club luncheon Jan. 14, according to STAT. By Alia Paavola - 1/16/19
A quarter of US hospitals cut staff to cope with rising drug costs from 2015 to 2017, study finds

Hospital drug spending jumped by 18.5 percent between 2015 and 2017, a rate that caused one in four hospitals to cut staff to ease budget pressures, a new study found. By Alia Paavola - 1/16/19

How 1 billionaire physician profited off of $74M Bristol-Myers Squibb-Celgene deal

Patrick Soon-Shiong, MD, a biotechnology entrepreneur and CEO of NantHealth, saw his net worth jump after pharmaceutical manufacturer Bristol-Myers Squibb announced a deal to purchase Celgene for roughly $74 million earlier this month, according to Forbes. By Alyssa Rege - 1/16/19
Elevate340B CEO Dr. Jake Thompson on why healthcare M&A has his attention

Jake Thompson, PharmD, serves as CEO of Elevate340B, a company dedicated to helping hospitals and clinics optimize their pharmaceutical purchasing. By Alia Paavola - 1/15/19
CompleteRx Regional Director of Pharmacy Joe Vargas offers 3 tips to manage drug spend

Joe Vargas is the regional director of pharmacy operations for CompleteRx, a pharmacy management, consulting and operations improvement provider. By Alia Paavola - 1/15/19
Froedtert Director of Ambulatory Pharmacy Dr. Jordan Spillane on the market disruptors that have her attention

Jordan Spillane, PharmD, has directed ambulatory pharmacy for Wauwatosa, Wis.-based Froedtert Hospital and the Medical College of Wisconsin for more than five years. She oversees five retail pharmacies within Froedtert facilities and outpatient anticoagulation services across the health system. By Alia Paavola - 1/15/19

Walmart splits with CVS in drug-pricing dispute

Walmart will leave the drugstore networks run by CVS Health's pharmacy benefit management unit because of a pricing dispute. By Alia Paavola - 1/15/19
No-haggle policy on drug pricing cost Medicare at least $14.4B, study finds

Medicare Part D could have saved $14.4 billion on the top 50 medications covered in 2016 if the program had been able to pay the same prices as the Department of Veterans Affairs, which often negotiates discounts, according to new analysis published in JAMA Internal Medicine cited by STAT. By Alia Paavola - 1/15/19
Government shutdown threatens drug approvals: 5 things to know

The partial government shutdown soon could impede the FDA's ability to review new drugs, a blow to drugmakers expecting to receive approval of their highly anticipated drugs, according to STAT. By Alia Paavola - 1/15/19
NewYork-Presbyterian pharmacy manager Dr. Susan Kokura on what needs to change in healthcare

Susan Kokura, PharmD, is the corporate clinical pharmacy manager at New York City-based NewYork-Presbyterian, a role she has held since July 2013. By Alia Paavola - 1/15/19
House panel launches drug-pricing probe of 12 pharma companies

The House Oversight Committee is investigating 12 pharmaceutical companies and their drug pricing strategies, according to STAT. By Alia Paavola - 1/15/19
Dispensary of Hope's pharmaceutical director Dr. Hillary Blackburn on what makes a dynamic, influential leader

Hillary Blackburn, PharmD, is the director of pharmaceutical services for Dispensary of Hope, where she consults with pharmacists to improve access to affordable medications and works to develop and implement programs to address the gaps in pharmaceutical care across the nation. By Alia Paavola - 1/14/19
Premier creates company to mitigate generic drug shortages

Healthcare improvement company Premier Inc. established a new company aimed at ensuring health systems have continuous and affordable access to medications, particularly those that lack competition or are in shortage. By Alia Paavola - 1/14/19
Leadership exodus continues at AstraZeneca, CMO to depart: 5 things to know

Adding to a wave of high-level departures, Sean Bohen, MD, PhD, AstraZeneca's CMO and executive vice president of global medicines development, will leave the company, according to Bloomberg. By Alia Paavola - 1/14/19
AHA submits legislative, regulatory recommendations to mitigate drug shortages

The American Hospital Association submitted several legislative, regulatory and best practice recommendations to the FDA Jan. 11 for managing new and chronic prescription drug shortages. By Alia Paavola - 1/14/19

Page 1 of 50

«
Prev
1
2
3
4
5
6
7
8
9
10
Next
»

Top 40 Articles from the Past 6 Months